• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT Back to Search Results
Catalog Number RONYX40012JX
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem Unspecified Tissue Injury (4559)
Event Date 04/23/2021
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During a procedure an attempt was made to use one resolute onyx rx coronary drug eluting stent to treat a moderately calcified and moderately tortuous lesion in the ostium rca with 90% stenosis.The device was inspected with no issues noted.Negative prep was performed with no issues noted.The device did not pass through a previously deployed stent.Resistance was encountered and excessive force was used.It was reported stent dislodgement occurred during delivery to the lesion.A femoral approach was selected for the patient with significantly meandering abdominal aorta.A 100 cm guiding catheter could not reach the coronary arteries, therefore a non medtronic guide extension catheter was used to engage right coronary artery.The lesion was predilated with a non medtronic balloon and the lesion was measured by intravascular ultrasound (ivus).Since there was residual stenosis, preparation was performed again with a larger non medtronic balloon.Ivus was attempted for the second time but was unsuccessful.The resolute onyx was selected for implantation, during advancement the stent was caught near the tip of the non medtronic gec and fell off.It was slowly retrieved by the onyx delivery system.The delivery system was removed and the stent remained in the non medtronic gec.After that, a non-medtronic balloon was used to pass through the stent, slightly inflated at the distal part and was pulled back.As strong resistance occurred on the way and the balloon broke, the entire gec was removed from the body.No patient injury was reported.
 
Manufacturer Narrative
Additional information: annex d, annex g codes added medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
MDR Report Key11731616
MDR Text Key247488530
Report Number9612164-2021-01669
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/16/2022
Device Catalogue NumberRONYX40012JX
Device Lot Number0010278102
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/23/2021
Initial Date FDA Received04/27/2021
Supplement Dates Manufacturer Received06/16/2021
Supplement Dates FDA Received06/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-